Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart monitoring breakthrough: 14 days vs. 24 hours for MVP patients

NCT ID NCT06378996

First seen Jan 04, 2026 · Last updated Jun 05, 2026 · Updated 29 times

Summary

This study tests whether wearing a heart monitor for 14 days can detect dangerous heart rhythms in people with mitral valve prolapse (a common heart valve condition) better than the usual 24-hour test. About 60 adults with MVP will wear a patch monitor for two weeks. The goal is to see how often risky rhythms occur and how much they vary day-to-day, which could lead to better detection and future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR ARRYTHMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UZ Leuven

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

    Contact

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

mitral valve prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.